Clinical Library · Hormonal Health
40:1 vs 20:1 inositol: why the ratio matters for PCOS
Ova Balance
Once-daily sachet: 2,000 mg myo + 50 mg D-chiro inositol (40:1), berberine HCl, Quatrefolic® folate.
What one small ratio-comparison trial found for 40:1, 20:1 and D-chiro-rich ratios, and how cautious to be.
The short answer
In a small 2019 trial that compared seven myo-inositol to D-chiro-inositol ratios, 40:1 gave the best ovulation and hormone results. Ratios richer in D-chiro (5:1 and below, or D-chiro alone) did clearly worse, and 20:1 gave in-between results. 1 The 40:1 ratio mirrors the balance of the two inositols found in healthy human plasma. 2
That said, the international PCOS guideline still describes the evidence for inositol as limited and does not recommend one specific type, dose or ratio. 3 Treat 40:1 as the best-studied option, not a guaranteed result.
Why two inositols, and why the balance?
Myo-inositol and D-chiro-inositol are both insulin "second messengers" inside cells, but they do different jobs:
- Myo-inositol supports glucose uptake and FSH signalling in the ovary, which matters for egg quality.
- D-chiro-inositol supports insulin-driven glycogen storage and, in the ovary, nudges androgen production.
The body converts myo into D-chiro as needed. In PCOS this conversion appears to run too fast in the ovary, leaving it short of myo-inositol even while other tissues are short of D-chiro. Researchers call this the "D-chiro-inositol paradox". 2 Adding a lot of D-chiro can make the ovarian imbalance worse, which is why a low D-chiro share tends to work better.
What the ratio-comparison trial found
A 2019 randomised trial gave 56 women with PCOS (8 per group) one of seven treatments for three months: D-chiro alone (0:1), or myo:D-chiro ratios of 1:3.5, 2.5:1, 5:1, 20:1, 40:1 or 80:1, at 2 g twice a day. 1
| Ratio (myo:D-chiro) | Result in the trial |
|---|---|
| 40:1 | Best progesterone (ovulation) and menses results (5 of 8 women had periods return); significant LH, SHBG and estradiol changes |
| 80:1 | Close to 40:1 for ovulation and LH (4 of 8 had periods return); smaller effects on SHBG and estradiol |
| 20:1 | In-between ovulation results (3 of 8 had periods return) |
| 5:1, 2.5:1, 1:3.5 and D-chiro alone | Little or no detectable ovulation benefit (0 to 1 of 8 had periods return) |
On metabolic markers, the HOMA index (a measure of insulin resistance) fell with every ratio, but the study found no significant difference between the ratios. Post-meal insulin also improved with all treatments without significant differences between them; only fasting insulin showed a clearer edge for 40:1 and 80:1. 1 So the evidence favouring 40:1 is mainly about ovulation and hormones, not metabolism.
This was a single trial with only 8 women per group, so larger independent replication is needed before drawing firm conclusions.
What 40:1 looks like in practice
The amount most often used in studies is 2,000 mg myo-inositol with 50 mg D-chiro-inositol per serving. 2 Effects on cycles and markers are usually assessed after about three months.
Who should be careful
- If you are pregnant, trying to conceive with fertility treatment, or taking diabetes medication, discuss inositol with your doctor first.
- Inositol does not replace diagnosis or prescribed care.
Where Ova Balance fits
Ova Balance provides 2,000 mg myo-inositol and 50 mg D-chiro-inositol (40:1) per daily sachet, with berberine HCl, Quatrefolic® folate and mineral cofactors. It is a nutritional supplement, not a treatment for PCOS.
Frequently asked questions
Is 40:1 better than 20:1 inositol?
In the one small trial that compared them, 40:1 gave better ovulation and hormone results than 20:1, which gave in-between results. Insulin-resistance (HOMA) improvements did not differ significantly between ratios. 1
Can I take D-chiro-inositol on its own?
D-chiro alone, and other D-chiro-rich ratios, showed little or no ovulation benefit in the ratio trial and may affect ovarian function. Most researchers favour a myo-dominant combination. 1, 2
How long does inositol take to work?
Most studies measure outcomes at around 12 weeks.
Sources
- Nordio M, Basciani S, Camajani E. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci. 2019;23(12):5512-5521. Full text (PDF)
- Unfer V, et al. Myo-inositol effects in women with PCOS: a meta-analysis and the D-chiro-inositol paradox. Gynecol Endocrinol / Int J Endocrinol reviews.
- 2023 International Evidence-based Guideline for the Assessment and Management of PCOS, Monash University.
